Alemtuzumab Decreased MRI Disease Activity Over 4 Years in Patients Who Switched From SC IFNB-1a: CARE-MS II Extension Study 4-Year Follow-upDaniel Pelletier,Michael Barnett,Aaron Boster,Giancarlo Comi,Hans-Peter Hartung,Alex Rovira,Sven Schippling,Barry Singer,Anthony Traboulsee,David H. Margolin,Sourav Santra,Douglas L. ArnoldNEUROLOGY(2017)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要